Align Technology, Inc. (NASDAQ:ALGN)
The Company designs, manufactures and markets the Invisalign system, a proprietary method for treating malocclusion, or the misalignment of teeth.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
My daughter says this company's patented teeth straightening methods are going to make braces obsolete.
Recs
I believe Align Technology will bring in 88.83 points considering a 15% S&P performance. My target is $ 6.19.
Recs
good growth stock
Recs
A very good PEG...Growing revenues and a business that targets a segment which will be ever appealing to those that are extremely conscious about their teeth which has a direct impact on one's looks and there are a lot of such People out there
Recs
Seems like a good product and they sell worldwide.
After backing out net cash, they should have a PE of 12. Their short ratio is 21%, so it is good for a bounce, and then probably longer.
Recs
Improving fundamentals
Recs
Align Technology makes and markets the Invisalign brand of dental orthodontic products. They have a good consumer presence and I believe international markets are also doing well. Align surprisingly weathered the recession well. That must be good news.
Recs
ALGN has a too high valuation compared to its sales potential.
Recs
dental products
Recs
New 52 week low. Double down on losing position. Alternative to metal and wire dental braces.
Recs
The stock is trading near its lowest prices ever, and this is one that's certain to rebound once the market improves. Could it go down further? Sure, but when consumers start spending money again, parents will spare no expense on their kids' health care, cosmetics included - and this will send the stock price back up.
The only two aspects of this stock that I'm not crazy about are it's Earnings Per Share (.34), and it's beta being a bit high. Otherwise, all their other stats seem very healthy. I especially like the fact that they're beefing up their spending on sales and marketing - a very smart move during a down economy that'll help position them for major gains during an economic turnaround.
Also, they've got a patented monopoly on their product. A few former employees of Align Technology tried to form their own company using what equated to the same product (the "Invisible Braces") at a cheaper cost to the consumer. Align Technologies sued them & won, and the spinoff company eventually dissolved. With that kind of power & control over their product, I'm optimistic that the Earnings Per Share will eventually improve.
Recs
Invisalign system stinks
Recs
Great product just needs to gain some steam. I have personally used Invisalign and it is outstanding compared to braces. Unless someone fixes our teeth genetically before birth, then there will always be a need for their product
Recs
Had been hit with warranted negatvie news but as it so often happens the street threw out the baby with the bathwater. It is a good product and is not bound by a bull or Bear market but by Vanity; Parents and children alike.
It has a devoted following of its product, myself included.
The street will redicover it and it will be moving UP.
Recs
There is no reason for this to be going up. First of all it is an elective procedure that is only FDA approved for people over 18, adults, not your typical population for braces, so insurace don't cover it at all. It is more expensive than traditional braces. It takes longer than traditional braces to correct problems. The users must wear these plastic mouthpieces all day every day unless you are eating (this limits treatment success because it is hard for anyone to wear these 24/7, no mater what the company tells you. Lastly, it is usually required to shave in-between teeth to achieve the desired result.
Now the Fundies: The company trades at an astounding P/E ratio. It has warned about future earnings. The CFO resigned. Cramer gave it a big "thumbs up."
This pig is being bought by the poor sappy dentists who pay a few grand for ALGN's course and think that they will be able to talk their patients into doing the treatment. Once they see that the treatment is not as successful as the company says it is, they stop doing the cases. Or better yet, wait until a few lawsuits hit the newspapers. They will be coming as it usually takes two years to complete treatment and it is just about due for a few lawsuits.
Recs
this stock just got crushed with a 30% loss but over all had been a rather good stock seeing it is nearing 1/2 its value it should make a come back next year, its an acquire on the way down and hold to recovery
Recs
down $6 to $22
Recs
Oct 16 Mad Money highlight. Has blown away numbers. Strong buy recommendation.
Recs
virtual monoply, beating est, no debt,
Recs
Cramer, Invisalign tooth straightening
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 34 : 1 2 Next »